• UK commits the equivalent of £330 million per year to Gavi, the Vaccine Alliance for the 2021-25 five-year period
  • Funding will support Gavi’s efforts to vaccinate 300 million children across the developing world, saving up to 8 million lives
  • Pledge will also support Gavi’s response to COVID-19 across Africa and Asia, as well as Gavi’s efforts to ensure the poorest countries recover from the impact of the COVID-19 pandemic on routine immunisation as we prepare for the availability of a COVID-19 vaccine

Geneva, 29 April 2020 – Gavi, the Vaccine Alliance has welcomed a pledge equivalent to £330 million per year for Gavi’s 2021-25 period announced today by Anne-Marie Trevelyan, Secretary of State for the UK Department for International Development (DFID).

The UK has been Gavi’s largest donor since its inception in 2000, playing a leading role in immunising a whole generation – over 760 million children – and helping to halve child mortality in 73 developing countries over the past two decades. The UK has also been a leading contributor to all Gavi’s innovative finance mechanisms, including the International Finance Facility for Immunisation. The UK pledge follows commitments from Germany and the Bill & Melinda Gates Foundation, USA, Saudi Arabia, TikTok, Reed Hastings & Patty Quillin, and Alwaleed Philanthropies.

“Gavi’s work has never been more important,” said Dr Ngozi Okonjo-Iweala, Chair of the Gavi Board. “Right now it is playing a vital role both keeping immunisation programmes going across the world, reducing the chances of there being further global disease outbreaks, as well as helping developing countries respond to the COVID-19 pandemic. As long as there are still pockets of this disease somewhere, everywhere is at risk. This pledge will make a huge difference to these efforts and I’d like to thank the UK, as Gavi’s biggest donor since its inception, for their leadership over the past two decades.”

“I’d like to thank the UK public for this pledge: an investment in Gavi is an investment in a safer, healthier world,” said Dr Seth Berkley, CEO of Gavi. “This funding will not only protect hundreds of millions of children against disease, it will also help health systems to repair and rebuild after the enormous impact of COVID-19 has subsided. This is our best shield against future pandemics which, as we have seen all too clearly in recent months, do not respect borders. Finally, it means we can continue our work leading international efforts to ensure universal access to a COVID-19 vaccine, as well as to maintain the infrastructure needed to deploy it at scale around the world, which offers our best means of ending this crisis.”

As well as pledging to Gavi’s 2021-25 period, the UK government will also host the Global Vaccine Summit on 4 June, which aims to raise a total of at least US$ 7.4 billion to support Gavi’s work over the next five years.

At Gavi’s last pledging conference, in Berlin in 2015, UK committed £1 billion (US$1.38 billion) to Gavi’s 2016-20 five-year period.


COVID-19 related

22 October 2021

Women Leaders in Polio Eradication: Dr. Folake Olayinka

Dr. Folake Olayinka speaks about overcoming gender-related barriers to immunization.

21 October 2021

“A moment of immense pride and joy”: Anuradha Gupta’s eight reflections on India’s billionth COVID-19 vaccine dose

As India celebrated its one-billionth COVID-19 vaccination, #VaccinesWork caught up with Anuradha Gupta, Gavi’s Deputy CEO and an Indian public health veteran.

21 October 2021

Combining COVID-19 and routine vaccination: Nigeria implements a “whole family” approach

The whole family approach is helping Lagos State tackle multiple disease outbreaks and helping families lead healthier lives.

21 October 2021

A million a day: Pakistan’s COVID-19 vaccine campaign hits its stride

After a halting start to its immunisation campaign, Pakistan has shifted into high gear, now administering a million doses a day. #VaccinesWork spoke to national health leaders and spent a morning at a rural vaccination centre to find out what…

20 October 2021

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19, with 21 vaccines now being rolled out in countries worldwide. Here is an at-a-glance overview of those vaccines and…

19 October 2021

Is it a cold or COVID-19? An expert explains

Research in the UK shows COVID-19 symptoms can be similar to the common cold. So, how can you tell the difference? Here, genetic epidemiologist Professor Tim Spector explains the latest data and what you need to know.

19 October 2021

Routine vaccines: extraordinary impact

Routine vaccines are anything but routine. These lifesavers are offered to infants in the months and years after birth, offering lifelong protection against some of the world's deadliest diseases. Their success means the diseases they protect…

Subscribe to our newsletter